Abeona Therapeutics (ABEO) Gains from Sales and Divestitures: 2022-2025
Historic Gains from Sales and Divestitures for Abeona Therapeutics (ABEO) over the last 2 years, with Sep 2025 value amounting to $1.4 million.
- Abeona Therapeutics' Gains from Sales and Divestitures rose 43.25% to $1.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $1.4 million, marking a year-over-year increase of 43.25%. This contributed to the annual value of $1.0 million for FY2024, which is 273.05% up from last year.
- As of Q3 2025, Abeona Therapeutics' Gains from Sales and Divestitures stood at $1.4 million, which was up 178.65% from $500,780 recorded in Q2 2025.
- In the past 5 years, Abeona Therapeutics' Gains from Sales and Divestitures ranged from a high of $1.4 million in Q3 2025 and a low of $27,526 during Q4 2022.
- In the last 3 years, Abeona Therapeutics' Gains from Sales and Divestitures had a median value of $659,824 in 2024 and averaged $635,035.
- Its Gains from Sales and Divestitures has fluctuated over the past 5 years, first spiked by 882.89% in 2023, then plummeted by 38.84% in 2025.
- Quarterly analysis of 4 years shows Abeona Therapeutics' Gains from Sales and Divestitures stood at $27,526 in 2022, then spiked by 882.89% to $270,550 in 2023, then skyrocketed by 273.05% to $1.0 million in 2024, then surged by 43.25% to $1.4 million in 2025.
- Its Gains from Sales and Divestitures was $1.4 million in Q3 2025, compared to $500,780 in Q2 2025 and $68,167 in Q1 2025.